1,751
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparisons of different treatment outcomes in IVF/ET patients with hydrosalpinx: a retrospective study

, , , , &
Article: 2249999 | Received 01 Mar 2023, Accepted 14 Aug 2023, Published online: 25 Aug 2023

References

  • G M H, A E H, R S S. Pathophysiology and management of proximal tubal blockage. Fertil Steril. 1999;71(5):1–6. doi:10.1016/s0015-0282(99)00014-x.
  • Serafini P, Batzofin J. Diagnosis of female infertility. A comprehensive approach. J Reprod Med. 1989;34(1):1–6.
  • Andersen AN, Yue Z, Meng FJ, et al. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod. 1994;9(10):1935–1938. doi:10.1093/oxfordjournals.humrep.a138362.
  • Melo P, Georgiou EX, Johnson N, et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev. 2020;10(10):CD002125. doi:10.1002/14651858.CD002125.pub4.
  • Camus E, Poncelet C, Goffinet F, et al. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod. 1999;14(5):1243–1249. doi:10.1093/humrep/14.5.1243.
  • Asrm PCO. Salpingectomy for hydrosalpinx prior to in vitro fertilization. Fertil. Steril. 2008;90(5):S66–S68. doi:10.1016/j.fertnstert.2008.08.089.
  • Ng K, Cheong Y. Hydrosalpinx - Salpingostomy, salpingectomy or tubal occlusion. Best Pract Res Clin Obstet Gynaecol. 2019;59:41–47. doi:10.1016/j.bpobgyn.2019.01.011.
  • Schlaff WD. A reconsideration of salpingectomy for hydrosalpinx before in vitro fertilization: why bother? Fertil Steril. 2019;111(4):650–651. doi:10.1016/j.fertnstert.2019.02.014.
  • Asrm PCOT. Role of tubal surgery in the era of assisted reproductive technology: a committee opinion. Fertil. Steril. 2015;103(6):e37-43. doi:10.1016/j.fertnstert.2015.03.032.
  • Chu J, Harb HM, Gallos ID, et al. Salpingostomy in the treatment of hydrosalpinx: a systematic review and meta-analysis. Hum Reprod. 2015;30(8):1882–1895. doi:10.1093/humrep/dev135.
  • Johnson N, van Voorst S, Sowter MC, et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev. 2010;2010(1):CD002125. doi:10.1002/14651858.CD002125.pub3.
  • Volodarsky-Perel A, Buckett W, Tulandi T. Treatment of hydrosalpinx in relation to IVF outcome: a systematic review and meta-analysis. Reprod Biomed Online. 2019;39(3):413–432. doi:10.1016/j.rbmo.2019.04.012.
  • Xiaona Lin GHHS. Chinese expert consensus on diagnosis and treatment of tubal infertility. J. Reprod. Med. 2018;27(11):1048–1056. doi:10.3969/j.issn.1004-3845.2018.11.002.
  • Uk NCCF. Fertility: assessment and treatment for people with fertility problems. Royal College of Obstetricians & Gynaecologists, London. 2013.
  • Tsiami A, Chaimani A, Mavridis D, et al. Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis. Ultrasound Obstet Gynecol. 2016;48(4):434–445. doi:10.1002/uog.15900.
  • Hammadieh N, Coomarasamy A, Ola B, et al. Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial. Hum Reprod. 2008;23(5):1113–1117. doi:10.1093/humrep/den071.
  • Zhou Y, Jiang H, Zhang WX, et al. Ultrasound-guided aspiration of hydrosalpinx occurring during controlled ovarian hyperstimulation could improve clinical outcome of in vitro fertilization-embryo transfer. J Obstet Gynaecol Res. 2016;42(8):960–965. doi:10.1111/jog.13013.
  • Arora P, Arora RS, Cahill D. Essure(®) for management of hydrosalpinx prior to in vitro fertilisation-a systematic review and pooled analysis. BJOG. 2014;121(5):527–536. doi:10.1111/1471-0528.12533.
  • Omurtag K, Grindler NM, Roehl KA, et al. How members of the society for reproductive endocrinology and infertility and society of reproductive surgeons evaluate, define, and manage hydrosalpinges. Fertil Steril. 2012;97(5):1095–1100. doi:10.1016/j.fertnstert.2012.02.026.
  • D'Arpe S, Franceschetti S, Caccetta J, et al. Management of hydrosalpinx before IVF: a literature review. J Obstet Gynaecol. 2015;35(6):547–550. doi:10.3109/01443615.2014.985768.
  • Hu L, Bu Z, Guo Y, et al. Comparison of different ovarian hyperstimulation protocols efficacy in poor ovarian responders according to the Bologna criteria. Int J Clin Exp Med. 2014;7(4):1128–1134.
  • Seli E, Kayisli UA, Cakmak H, et al. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Hum Reprod. 2005;20(11):3012–3017. doi:10.1093/humrep/dei188.
  • Ersahin AA, Ersahin S, Gungor ND. Surgical removal of hydrosalpinx improves endometrium receptivity by decreasing nuclear factor-kappa B expression. Reprod Sci. 2020;27(3):787–792. doi:10.1007/s43032-019-00136-y.
  • Strandell A, Waldenström U, Nilsson L, et al. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Hum Reprod. 1994;9(5):861–863. doi:10.1093/oxfordjournals.humrep.a138606.
  • Ajonuma LC, Ng EH, Chan HC. New insights into the mechanisms underlying hydrosalpinx fluid formation and its adverse effect on IVF outcome. Hum Reprod Update. 2002;8(3):255–264. doi:10.1093/humupd/8.3.255.
  • Mukherjee T, Copperman AB, McCaffrey C, et al. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy. Fertil Steril. 1996;66(5):851–853. doi:10.1016/s0015-0282(16)58652-x.
  • Bao H, Qu Q, Huang X, et al. Impact of hydrosalpinx fluid on early human embryos. Syst Biol Reprod Med. 2017;63(4):279–284. doi:10.1080/19396368.2017.1319993.
  • Ng EH, Ajonuma LC, Lau EY, et al. Adverse effects of hydrosalpinx fluid on sperm motility and survival. Hum Reprod. 2000;15(4):772–777. doi:10.1093/humrep/15.4.772.
  • Vandromme J, Chasse E, Lejeune B, et al. Hydrosalpinges in in-vitro fertilization: an unfavourable prognostic feature. Hum Reprod. 1995;10(3):576–579. doi:10.1093/oxfordjournals.humrep.a135992.
  • Strandell A, Lindhard A, Waldenström U, et al. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod. 1999;14(11):2762–2769. doi:10.1093/humrep/14.11.2762.
  • Strandell A, Lindhard A, Waldenström U, et al. Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomized controlled trial. Hum Reprod. 2001;16(11):2403–2410. doi:10.1093/humrep/16.11.2403.
  • Kontoravdis A, Makrakis E, Pantos K, et al. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril. 2006;86(6):1642–1649. doi:10.1016/j.fertnstert.2006.05.032.
  • Gelbaya TA, Nardo LG, Fitzgerald CT, et al. Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges. Fertil Steril. 2006;85(5):1464–1468. doi:10.1016/j.fertnstert.2005.10.036.
  • Almog B, Wagman I, Bibi G, et al. Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal. Fertil Steril. 2011;95(8):2474–2476. doi:10.1016/j.fertnstert.2011.03.032.
  • Fouda UM, Sayed AM. Effect of ultrasound-guided aspiration of hydrosalpingeal fluid during oocyte retrieval on the outcomes of in vitro fertilisation-embryo transfer: a randomised controlled trial (NCT01040351). Gynecol Endocrinol. 2011;27(8):562–567. doi:10.3109/09513590.2010.507290.
  • Xu B, Zhang Q, Zhao J, et al. Pregnancy outcome of in vitro fertilization after essure and laparoscopic management of hydrosalpinx: a systematic review and meta-analysis. Fertil Steril. 2017;108(1):84–95.e5. doi:10.1016/j.fertnstert.2017.05.005.
  • Dreyer K, Lier MC, Emanuel MH, et al. Hysteroscopic proximal tubal occlusion versus laparoscopic salpingectomy as a treatment for hydrosalpinges prior to IVF or ICSI: an RCT. Hum Reprod. 2016;31(9):2005–2016. doi:10.1093/humrep/dew050.